These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8200085)
1. Activated ras oncogene and specifically acquired resistance to cisplatin in human mammary epithelial cells: induction of DNA cross-links and their repair. Levy E; Baroche C; Barret JM; Alapetite C; Salles B; Averbeck D; Moustacchi E Carcinogenesis; 1994 May; 15(5):845-50. PubMed ID: 8200085 [TBL] [Abstract][Full Text] [Related]
2. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair. Chao CC Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556 [TBL] [Abstract][Full Text] [Related]
3. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts. Calsou P; Frit P; Salles B Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197 [TBL] [Abstract][Full Text] [Related]
4. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). Plooy AC; van Dijk M; Berends F; Lohman PH Cancer Res; 1985 Sep; 45(9):4178-84. PubMed ID: 3928152 [TBL] [Abstract][Full Text] [Related]
5. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. Hill BT; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Bedford P Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):75-83. PubMed ID: 2380098 [TBL] [Abstract][Full Text] [Related]
6. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells. Masumoto N; Nakano S; Fujishima H; Kohno K; Niho Y Int J Cancer; 1999 Mar; 80(5):731-7. PubMed ID: 10048975 [TBL] [Abstract][Full Text] [Related]
7. Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cells. Chao CC Eur J Pharmacol; 1994 Aug; 268(3):347-55. PubMed ID: 7805758 [TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin. Larminat F; Cambois G; Zdzienicka MZ; Defais M FEBS Lett; 1998 Oct; 437(1-2):97-100. PubMed ID: 9804179 [TBL] [Abstract][Full Text] [Related]
9. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene. Lebeau J; Le Chalony C; Prosperi MT; Goubin G Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862 [TBL] [Abstract][Full Text] [Related]
10. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Zhen W; Link CJ; O'Connor PM; Reed E; Parker R; Howell SB; Bohr VA Mol Cell Biol; 1992 Sep; 12(9):3689-98. PubMed ID: 1380646 [TBL] [Abstract][Full Text] [Related]
11. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines. Aida T; Bodell WJ Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate. Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724 [TBL] [Abstract][Full Text] [Related]
13. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Lau DH; Lewis AD; Ehsan MN; Sikic BI Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140 [TBL] [Abstract][Full Text] [Related]
14. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
15. Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin beta 3 and increased expression of c-myc. Krief P; Saint-Ruf C; Bracke M; Boucheix C; Billard C; Billard M; Cassingena R; Jasmin C; Mareel M; Azzarone B Int J Cancer; 1989 Apr; 43(4):658-64. PubMed ID: 2495251 [TBL] [Abstract][Full Text] [Related]
16. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Bungo M; Fujiwara Y; Kasahara K; Nakagawa K; Ohe Y; Sasaki Y; Irino S; Saijo N Cancer Res; 1990 May; 50(9):2549-53. PubMed ID: 2158392 [TBL] [Abstract][Full Text] [Related]
17. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair. Chao CC Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407 [TBL] [Abstract][Full Text] [Related]
18. DNA cross-linking and cytotoxicity induced by cis-diamminedichloroplatinum(II) in human normal and tumor cell lines. Laurent G; Erickson LC; Sharkey NA; Kohn KW Cancer Res; 1981 Sep; 41(9 Pt 1):3347-51. PubMed ID: 7196283 [TBL] [Abstract][Full Text] [Related]
19. Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells. Jones JC; Zhen WP; Reed E; Parker RJ; Sancar A; Bohr VA J Biol Chem; 1991 Apr; 266(11):7101-7. PubMed ID: 2016318 [TBL] [Abstract][Full Text] [Related]
20. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]